-
FBXO36 is inferred to be an F-box substrate-recognition adaptor of an SCF/CRL1 complex, but no endogenous FBXO36 substrate has been directly validated in the literature.
"although **no endogenous FBXO36 substrate has been directly validated** in the retrieved literature"
-
The strongest direct functional evidence is from a TNF/NF-kappa-B RNAi screen in which FBXO36 depletion increased TNF-induced nuclear NF-kappa-B accumulation and altered I-kappa-B/JNK phosphorylation, consistent with FBXO36 modulating SCF-dependent ubiquitin signaling.
"**FBXO36 is likely an F-box adaptor protein that can modulate SCF-dependent ubiquitin signaling, with experimental evidence that FBXO36 depletion alters TNF pathway signaling outputs (NF-κB nuclear accumulation kinetics, I-κB and JNK phosphorylation dynamics, and TNF+CHX apoptosis sensitivity) in human cell lines.**"
-
FBXO36 depletion increased steady-state beta-catenin, interpreted as a possible modifier of the SCF-betaTrCP axis, but this does not establish beta-catenin as a direct FBXO36 substrate.
"depletion of FBXO36 increased steady-state **β-catenin** levels. They interpreted this as supportive of a possible role as a modifier of the **SCF–βTrCP** axis"